Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on September 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

2D High-Density Multi-Electrode Array Electrophysiology Platform

Awarded
RFQ_CBER-2026-135968Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334516
New
SLED
RFQ #2026061 - SB Option- 3DATX Mini PEMS and 1065 Upgrades
Solicitation # 2026061
Solicitation RFQ 2026061 is issued by the California Air Resources Board to procure one new 1065-compliant 3DATX parSYNC measurement system and two upgrade packages for existing systems. These devices are utilized as low-cost alternatives for managing high hydrocarbon emissions during vehicle surveillance, in-use compliance, and emissions testing, adhering to specific California and federal regulations. The procurement is designated as a Small Business Option, meaning bids are exclusively accepted from DGS registered small or micro businesses. Bids must be submitted by November 17, 2026, and any proposal valued at 250,000 dollars or more will be rejected as non-responsive. The contract will be awarded to the lowest responsive and responsible bidder on an all-or-nothing basis. Selected vendors must deliver the equipment to Riverside, California, within 45 working days of the purchase order execution under FOB Destination terms. All hardware includes a one-year limited warranty, and the state will verify operational compliance within 30 business days of delivery. Payment is governed by the California Prompt Payment Act, with undisputed invoices paid within 45 days. Bidders must provide comprehensive documentation, including small business certifications, DVBE declarations, and a disclosure regarding the use of generative AI to avoid disqualification.
State Air Resources Board

POSTED

about 6 hours ago

DEADLINE

in 14 days
NAICS: 334516
New
Federal
Vacuum Chamber
Solicitation # RFQ501580
UT-Battelle, LLC, the management and operating contractor for Oak Ridge National Laboratory (ORNL), is soliciting quotes under RFQ 501580 for a vacuum chamber and associated components for the Research Accelerator Division. The procurement includes a modular vacuum system consisting of an Ideal Vacuum Cube 6x12x12 Short Cube Advanced Development Kit, a New Edwards Dual Stage Twin Head D-Lab 10-8 Diaphragm Vacuum Pump, and various instrumentation and hardware such as MKS Granville Phillips gauges, power supply adapters, ISO-KF flanges, centering rings, and electrical coaxial feedthroughs. All technical specifications are defined by the specific part numbers provided in the Bill of Materials. Deliveries are to be made to 1 Bethel Valley Road, Oak Ridge, Tennessee. The contract is governed by standard terms and conditions for commercial products and services under the Simplified Acquisition Threshold, incorporating mandatory US Government regulatory and DOE prime contract flowdown clauses. Offerors must provide abbreviated representations and certifications, including their Unique Entity ID, and certify compliance with the Buy American Act, export controls, and prohibitions on covered telecommunications equipment. Key regulatory requirements include adherence to DOE cybersecurity programs, personnel security standards, and environmental health and safety protocols for onsite work. Compliance with FAR clauses regarding anti-kickback procedures, equal opportunity for veterans, and combating trafficking in persons is required based on the final contract value thresholds.
Ornl Ut-Battelle Llc-Doe Contractor

POSTED

about 15 hours ago

DEADLINE

in about 19 hours

AI Contract Overview

Show more

The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, is soliciting quotations for a 2D High-Density Multi-Electrode Array (MEA) Electrophysiology Platform under RFQ_CBER-2026-135968. This unrestricted, firm-fixed-price acquisition includes the delivery of a complete platform with a dedicated workstation, a perpetual software license, five recording plates, and essential accessories. The scope of work encompasses on-site installation, system verification, calibration, and hands-on training for two government personnel. The system must be newly manufactured and capable of simultaneous recording from at least 2,000 electrodes per well to characterize drug-induced neural activity. Award will be made based on the Lowest Price Technically Acceptable (LPTA) method, with technical evaluations conducted on a pass/fail basis against mandatory minimum requirements. The contract includes a base requirement and three optional one-year periods for preventative maintenance and repair, with a total potential duration of five years and seventy-five calendar days. A two-year manufacturer warranty begins upon final government acceptance, which is contingent on a successful demonstration recording using control drugs and whole-network spatial activity visualization. Final acceptance will be communicated within five business days following the completion of all installation and verification activities. Quotations are due by September 23, 2026, and must include technical compliance documentation, pricing for all CLINs, and country of origin information in accordance with the Trade Agreements Act.

General Info

FDA seeks a 2D MEA Electrophysiology Platform via LPTA award by September 23, 2026.

Contract Value

$293,250

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Place of Performance

MD, USA

Set-Aside

NONE

Award Issued Date

Documents

2
PDF, High priority: read this first2 pages · amendment
High
PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseAwarded
Posted

Combined Synopsis

Notice updated

The notice description changed.

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts2 people available
OfficeRockville, MD, 20852, USA

Full Description

Show more

The purpose of this amendment is to provide clarification regarding the Government’s final acceptance timeframe. No further questions will be addressed regarding this solicitation. The solicitation closing date and time will not be extended.


****************************************************************************************************************************************************


The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), is issuing this combined synopsis/solicitation for the acquisition of a 2D High-Density Multi-Electrode Array (MEA) Electrophysiology Platform, including required hardware, software, accessories, initial consumables, installation, system verification, calibration, training, warranty coverage, and preventative maintenance option periods.


This solicitation is issued as a Request for Quotation (RFQ) for commercial products and services. This announcement constitutes the only solicitation; quotations are being requested, and a separate written solicitation will not be issued.


This requirement is being solicited on an unrestricted basis.


NAICS Code: 334516 – Analytical Laboratory Instrument Manufacturing
PSC: 6640 – Laboratory Equipment and Supplies
Set-Aside: None – Unrestricted
Basis for Award: Lowest Price Technically Acceptable (LPTA)


Award will be made to the responsible offeror whose quotation is determined to be technically acceptable and represents the lowest evaluated price. Technical acceptability will be evaluated on a pass/fail basis against the minimum requirements identified in the solicitation and attached Requirements Document. Quotations that fail to meet any mandatory minimum requirement may be determined technically unacceptable and will not be considered for award.


The solicitation includes a base requirement consisting of the equipment and associated supplies/services, a two-year warranty from final Government acceptance, and three one-year option periods for preventative maintenance and repair services.


The solicitation is subject to the Trade Agreements Act. Offerors shall provide the country of origin for all offered end products and complete all applicable representations and certifications.


Questions: All questions regarding this solicitation shall be submitted in writing no later than September 17, 2026, at 10:00 AM Eastern Time. Questions received after the deadline may not be answered. Responses to questions may be posted through an amendment to the solicitation.


Quotation Due Date: Quotations shall be submitted no later than September 23, 2026, at 10:00 AM Eastern Time.


Offerors shall submit a complete quotation that includes, at a minimum, technical documentation demonstrating compliance with the solicitation requirements, completed technical compliance information, pricing for the base requirement and all option periods, warranty information, delivery lead time, country of origin for all offered items, UEI, and confirmation of active SAM.gov registration.


All solicitation documents, attachments, amendments, and Government responses to questions will be posted to SAM.gov. Offerors are responsible for monitoring SAM.gov for amendments or other updates to this solicitation.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541611
New
Federal
FDA/CDRH Scientific Technical Capacity for Regulatory Review
Solicitation # 75F40127Q00006
The FDA Center for Devices and Radiological Health (CDRH) has issued a Sources Sought Notice under solicitation 75F40127Q00006 to conduct market research for a Blanket Purchase Agreement. The objective is to secure advanced professional and scientific consultants to provide technical capacity for regulatory reviews across the total product lifecycle of medical devices. Required expertise spans a vast array of disciplines, including biomedical engineering, computer science, cybersecurity, data science, and various clinical specialties such as anesthesiology, toxicology, and virology. These consultants will support critical activities including research, digital health consultations, auditing, and the evaluation of the safety and effectiveness of devices approved, cleared, or authorized by the FDA. The anticipated period of performance includes a twelve-month base year starting January 30, 2027, followed by four twelve-month option years and a final six-month extension option ending July 29, 2032. Services will be performed both remotely via the FDA network and on-site at the White Oak Headquarters in Silver Spring, Maryland. The government is considering NAICS code 541611 for this effort and is seeking information from large and small businesses, including various socio-economic categories. Interested vendors must submit their responses, including a completed Vendor Feedback Form and capability statement, to the designated contract specialists by 2:00 PM EST on November 17, 2026.
Administrative Management and General Management Consulting Services

POSTED

about 15 hours ago

DEADLINE

in 15 days
View Details
NAICS: 541714
New
Federal
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Solicitation # FDABAA-27-00123
The FY27 FDA Broad Agency Announcement (BAA), solicitation number FDABAA-27-00123, seeks basic and applied research and development proposals to advance regulatory science and innovation. Managed by the FDA Office of Acquisitions and Grant Services, this initiative aims to utilize capabilities from industry and academia to improve technologies, materials, processes, and methods that support the FDA's mission to protect and promote national health. The BAA is open to all responsible sources, with strong encouragement for small business participation. Proposals are evaluated based on overall best value, focusing on scientific and technical merit, the degree of innovation, the feasibility of proposed plans, and the potential to overcome critical barriers in the field. Submissions must be delivered as searchable PDFs via email by January 22, 2027, at 5:00 PM EST. The application process requires a concept paper limited to three pages and a full proposal divided into a technical volume (50-page limit) and a cost volume. Key requirements include valid SAM.gov registration, adherence to strict page limits, and the provision of detailed key personnel qualifications. Awardees must comply with specific regulatory standards, including Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and Good Clinical Practice (GCP) where applicable. Additionally, contractors must maintain strict organizational conflict of interest disclosures and provide monthly technical progress reports. Non-small business concerns submitting proposals exceeding 900,000 dollars are required to provide a Small Business Subcontracting Plan.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

4 days ago

DEADLINE

in 3 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS